Discovering Tomorrow’s Medicines Today

Dr. Sophie Venet (pictured) closely examines the telltale tracks of a culture sample in a petri dish. Welcome to Novimmune! A Swiss biotech company focused
on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.
Promo01

Breakthrough Targeted Medicines

Explore our pipeline of novel antibodies to treat inflammatory and immune-related diseases, cancer, and orphan indications.

Promo02

World-Class Talent and Experience

Meet some of the people
who have made our scientific research and clinical develop-ment advances possible.

Promo03

Cutting-Edge Technology Platforms

Peek inside our proprietary technology plaforms which are used to generate monoclonal and bispecific antibodies.

Promo04

Helping Patients
Heal Themselves

Discover how the human immune system works and how antibody drug therapy can help restore patient health.